Skip to main content
. 2022 Jan 4;480(7):1287–1301. doi: 10.1097/CORR.0000000000002107

Table 3.

Most definitive model after the hierarchical logistic regression analyses (n = 1824) using sociodemographics, clinical characteristics, experience, and mental health characteristics explaining undergo treatment again

Variables Range (when applicable) Nonstandardized OR (95% CI) Standardized OR (95% CI) p value
Age in years 0.99 (0.97-1.01) 0.90 (0.75-1.09) 0.28
Sex (male) 1.11 (0.80-1.54) 1.11 (0.80-1.54) 0.53
BMI 0.99 (0.96-1.02) 0.93 (0.81-1.07) 0.33
Dominant side treated (yes) 0.84 (0.63-1.11) 0.84 (0.63-1.11) 0.23
Workload (reference = unemployed)
 Light 1.30 (0.87-1.93) 1.30 (0.87-1.93) 0.20
 Medium 0.85 (0.56-1.27) 0.85 (0.56-1.27) 0.42
 Heavy 0.77 (0.44-1.35) 0.77 (0.44-1.35) 0.35
Symptom duration in months 1.01 (1.00-1.01) 1.27 (1.09-1.52) < 0.01
Second opinion (no) 1.30 (0.52-3.00) 1.30 (0.52-3.00) 0.55
Recurrence (yes) 1.00 (0.62-1.64) 1.00 (0.62-1.64) 0.99
Smoking (no) 0.87 (0.56-1.32) 0.87 (0.56-1.32) 0.51
EQ-5D VAS self-rated health 0-100 1.00 (0.99-1.01) 0.96 (0.82-1.12) 0.65
Change in VAS pain during load 0-100 1.02 (1.01-1.02) 1.74 (1.48-2.07) < 0.001
Change in VAS function 0-100 1.02 (1.01-1.02) 1.80 (1.54-2.11) < 0.001
PREM shared decision-making positive (yes) 1.45 (1.06-1.99) 1.45 (1.06-1.99) 0.02
PREM pros/cons positive (yes) 2.05 (1.50-2.80) 2.05 (1.50-2.80) < 0.001
PREM advice positive (yes) 1.52 (1.11-2.07) 1.52 (1.11-2.07) 0.01
B-IPQ consequences 0-10 0.95 (0.87-1.02) 0.87 (0.71-1.06) 0.17
B-IPQ timeline 0-10 1.01 (0.95-1.07) 1.02 (0.86-1.21) 0.82
B-IPQ personal control 0-10 1.02 (0.97-1.08) 1.06 (0.92-1.23) 0.41
B-IPQ identity 0-10 1.00 (0.93-1.07) 1.00 (0.82-1.20) 0.96
B-IPQ concern 0-10 0.99 (0.92-1.06) 0.96 (0.79-1.17) 0.71
B-IPQ coherence 0-10 1.08 (1.01-1.16) 1.17 (1.01-1.34) 0.03
B-IPQ emotional response 0-10 1.00 (0.94-1.07) 1.01 (0.83-1.23) 0.93
CEQ credibility score 3-27 1.11 (1.06-1.18) 1.44 (1.20-1.73) < 0.001
CEQ expectancy score 3-27 0.99 (0.94-1.04) 0.96 (0.78-1.18) 0.71
PCS total score 0-52 1.00 (0.98-1.02) 0.97 (0.82-1.15) 0.73
PHQ-4 total score 0-12 0.98 (0.90-1.06) 0.96 (0.81-1.13) 0.59

Nonstandardized and standardized odds ratios, 95% CIs, and p values are displayed, along with the AUC and Nagelkerke r2 for the model; the nonstandardized ORs in our most definitive model indicate that with every unit increase in either a continuous, dichotomous, or categorical independent variable, the odds of being willing to undergo the treatment again increase or decrease by the value of the nonstandardized OR; standardized ORs are converted to the same scale, which makes it easier to make between-variable comparisons and determine the relative association of each explanatory variable. Interpretation AUC (ability of the model to discriminate between willing or not willing to undergo again) = 0.81; interpretation of the Nagelkerke r2 (goodness of fit of the model) = 0.29; EQ-5D = EuroQol-5 Dimensions; PREM = patient-reported experience measures; B-IPQ = Brief Illness Perception Questionnaire; CEQ = Credibility/Expectancy Questionnaire; PCS = Pain Catastrophizing Scale; PHQ = Patient Health Questionnaire; OR = odds ratio.